Research and development stand at the heart of our mission, driving our ability to create innovative solutions for laboratories that improve lives around the world. With a new technique that uses color temperature and relatively simple data processing, Roche scientists have found a way to triple the number of targets (e.g., viruses or bacteria) that can be detected in a patient sample with a single diagnostic test. The innovation, called TAGS — short for Temperature-Activated Generation of Signal — created by Igor Kozlov, a Roche scientist, has the potential to help healthcare providers diagnose and ultimately treat infections that have similar symptoms like COVID-19 and the flu while reducing cost and environmental waste. With these types of illnesses, isolating the cause can be critical to providing appropriate treatment. #Diagnostics #TAGS
Roche Diagnostics USA
生物技术研究
Indianapolis，Indiana 93,704 位关注者
We're passionate about transforming healthcare by delivering novel diagnostic solutions to help improve patients' lives.
关于我们
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche Diagnostics is the world leader in in-vitro diagnostics. Working at Roche means working at the forefront of innovation. Our cutting-edge technologies and healthcare solutions were occasionally developed with unconventional methods but always with the highest standard of quality in mind. Our Roche Diagnostics USA offices are located in: ? Boston (MA) ? Branchburg (NJ) ? Indianapolis (IN) ? Pleasanton (CA) ? Santa Clara (CA) ? San Jose (CA) ? Seattle (WA) ? Tucson (AZ) Follow our page to be kept up to date with news about Roche Diagnostics in the U.S.! Visit our Careers website to view our current openings: www.roche.com/careers
- 网站
-
https://usdiagnostics.roche.com
Roche Diagnostics USA的外部链接
- 所属行业
- 生物技术研究
- 规模
- 5,001-10,000 人
- 总部
- Indianapolis，Indiana
- 创立
- 1896
- 领域
- in-vitro、Biotechnology、Molecular Sequencing、biotech、molecular和sequencing
动态
-
This is a webinar you do not want to miss, and it's only one week away. The Latest Innovation in Point of Care Testing. Join us on March 5th to learn more about the cobas? liat STI assays. Register now: https://lnkd.in/gkx_KSUq
-
-
We are excited to announce that Roche has received 510(k) clearance from the FDA for the Elecsys? sFlt-1/PlGF ratio for preeclampsia. Read the full release: https://lnkd.in/g5dyQjdE #PreeclampsiaAwareness #HighRiskPregnancy
-
-
By harnessing cutting-edge technologies and fostering collaboration, we are transforming healthcare globally — making it more accessible, personalized and sustainable for everyone. Our commitment to innovation drives the development of solutions that increases efficiency, improve outcomes and revolutionize health care for all. #diagnostics
-
Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU. View the full release: https://lnkd.in/gyMTe8GA #breastcancer
-
-
We are honored to be recognized as one of Glassdoor's Best Places to Work in 2025! Thank you to our incredible employees, whose valuable feedback earned us this spot. Your daily dedication and inspiration make us truly exceptional. Interested in joining our team? Click here https://lnkd.in/gTjK4C6Y #BestPlacesToWork? #WeAreRoche #glassdoor
-
-
This is a groundbreaking week for Roche, as we are the first to receive FDA 510(k) clearance for a blood test in the U.S. measuring Lp(a) in molar units. Read more: https://lnkd.in/gMKUpBgg
-
-
The elimination of #CervicalCancer is well within reach. But it still causes approximately 4,000 deaths in the U.S. each year. Screening is a key factor behind changing this statistic. We hear many reasons for not getting screened—ranging from a perceived stigma associated with a sexually transmitted infection to living in a medically underserved area. Cultural sensitivities, modesty or embarrassment related to the exam can also pose barriers. Women and people with a cervix – how can we make screening easier and more accessible for you? In this article, Vanessa Bennett, senior international business leader, and Cassandra Ricci, Roche senior manager, alliance development and federal government affairs, share insights on the importance of access and the power of partnerships, including the relationship we have strengthened with Cervivor, Inc. https://lnkd.in/gPARbn8U #CervicalCancerMonth #CervicalHealthMonth #CervicalCancerAwareness
-
-
We’ve received FDA clearance with CLIA waiver for cobas? liat molecular tests to aid in diagnoses of sexually transmitted infections at the point of care. Learn how this expands access for patients in decentralized settings: https://lnkd.in/gXj3bTWt #STIs
-